Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Heterogeneous associations of socioeconomic status with metabolic disease in racial and ethnic subgroups in the United States: A cross-sectional cohort study in NHANES and All Of Us.

PloS one·2026
Same author

Screening for Missed Opportunities for Diagnosis in the ED Using eTriggers and Large Language Models.

JAMA network open·2026
Same author

Multimodal foundation models exploit text to make medical image predictions.

Nature communications·2026
Same author

Learning Normal Representations for Blood Biomarkers.

ArXiv·2026
Same author

Leveraging Artificial Intelligence in Allergy, Asthma, and Immunology With Environmental Exposures.

Allergy·2026
Same author

Performance of Local Large Language Models for Adjudicating Heart Failure Hospitalizations.

Circulation·2026

Related Experiment Video

Updated: Mar 27, 2026

Digital PCR-based Competitive Index for High-throughput Analysis of Fitness in Salmonella
07:11

Digital PCR-based Competitive Index for High-throughput Analysis of Fitness in Salmonella

Published on: May 13, 2019

10.2K

REPRODUCIBLE AND SHAREABLE QUANTIFICATIONS OF PATHOGENICITY.

Arjun K Manrai1, Brice L Wang, Chirag J Patel

  • 1Department of Biomedical Informatics, Harvard Medical School, 10 Shattuck St., Boston, MA, 02115, USA, Manrai@post.harvard.edu.

Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing
|January 19, 2016
PubMed
Summary

This study introduces a computational framework to quantify genetic variant pathogenicity, enabling reassessment of disease risk. The accessible platform supports researchers in evaluating genetic variation across thousands of diseases.

More Related Videos

Development and Validation of a Quantitative PCR Method for Equid Herpesvirus-2 Diagnostics in Respiratory Fluids
09:57

Development and Validation of a Quantitative PCR Method for Equid Herpesvirus-2 Diagnostics in Respiratory Fluids

Published on: March 17, 2016

29.2K
Tractable Mammalian Cell Infections with Protozoan-primed Bacteria
13:54

Tractable Mammalian Cell Infections with Protozoan-primed Bacteria

Published on: April 2, 2013

11.0K

Related Experiment Videos

Last Updated: Mar 27, 2026

Digital PCR-based Competitive Index for High-throughput Analysis of Fitness in Salmonella
07:11

Digital PCR-based Competitive Index for High-throughput Analysis of Fitness in Salmonella

Published on: May 13, 2019

10.2K
Development and Validation of a Quantitative PCR Method for Equid Herpesvirus-2 Diagnostics in Respiratory Fluids
09:57

Development and Validation of a Quantitative PCR Method for Equid Herpesvirus-2 Diagnostics in Respiratory Fluids

Published on: March 17, 2016

29.2K
Tractable Mammalian Cell Infections with Protozoan-primed Bacteria
13:54

Tractable Mammalian Cell Infections with Protozoan-primed Bacteria

Published on: April 2, 2013

11.0K

Area of Science:

  • Genetics
  • Computational Biology
  • Bioinformatics

Background:

  • Hundreds of thousands of genetic variations are linked to diseases, but most lack quantitative risk estimates.
  • Reclassifying pathogenic variations requires scalable, feasible methods for broad human disease application.

Purpose of the Study:

  • To develop a shareable computational framework for quantifying pathogenicity assertions.
  • To extend pathogenicity reassessments to over 6,000 diseases and 160,000 assertions in the ClinVar database.

Main Methods:

  • Developed a reproducible "digital notebook" integrating code, annotations, and mathematical expressions.
  • Utilized a freely accessible statistical environment for computational analysis.
  • Extended previous disease-specific assessments to a large-scale dataset.

Main Results:

  • Created a platform to quantify pathogenicity assertions for over 6,000 diseases.
  • Integrated 160,000 assertions from the ClinVar database.
  • Released a website for accessing pathogenic variation data and risk calculations.

Conclusions:

  • The computational framework facilitates the prioritization of variants for reassessment.
  • Enables tailoring of genetic model parameters to reveal uncertainties in risk assessments.
  • Supports variant reassessments by providing disease-specific information and risk calculations.